BioSpace News Archive

Portfolio presenting GC85A with Image Post-processing Engine (IPE) S-Vue™3.02 for greater diagnostic confidence with 50% dose reduction*

Mandate Requires Electronic Submission of Drug Master Files Using Trusted Digital Certificates

Urovant Sciences announced that it has strengthened its management team through the appointment of five senior executives: Cornelia Haag-Molkenteller M.D., Ph.D., as Chief Medical Officer, Michael McFadden as Chief Commercial Officer, Bryan E. Smith as General Counsel, Christine Ocampo as Senior Vice President and Chief Accounting Officer, and Nori Ebersole as Senior Vice President and Chief Human Resources Officer.

Leading kidney care services provider and nationally recognized kidney transplant program set new standards in continuum of care and data accuracy of waitlisted patients

DrFirst announced that Linda Fischer, the company’s vice president of product strategy, will be a presenter on the panel entitled “State of the Opioid Crisis: Moving Forward. What’s at Stake Now?” at the Critical Connections’ Opioid Crisis Symposium, to be held April 25-26 at the Hyatt Regency Baltimore Inner Harbor in Baltimore, Maryland.

April 24, 2018 11:00 UTC Alpine Immune Sciences Appoints Life Sciences Executive Chris Peetz to its Board of Directors SEATTLE--( BUSINESS WIRE )-- Alpine Immune Sciences, Inc. (NASDAQ:ALPN) announced today the appointment of Chris Peetz to its Board of Directors. Mr. Peetz, an experienced life sciences executive, currently serves as the Chief Executive Officer of Flashlight Therapeutics. “We are pleased to have Chris j

CMP-001 Clinical Studies Expand into Second Tumor Type

Innovative Radiation Therapy Device Enables Cancer Center to Provide Faster, Extremely Precise Radiation Treatments

St. Jude Children’s Research Hospital® patient Austin will join NFL Commissioner Roger Goodell onstage at AT&T Stadium to announce the Denver Broncos’ Round 1 pick on Thursday, April 26.

The new products are Monoclonal Antisera and Anti-Human Globulin.